Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro

The Journal of Clinical Investigation
A E CalogeroP W Gold

Abstract

To further our understanding of the functional role of catecholaminergic systems in regulating hypothalamic corticotropin-releasing hormone (CRH) secretion, we assessed the direct effects of a multiplicity of catecholamine agonists and antagonists on hypothalamic CRH secretion. To accomplish this, we used an in vitro rat hypothalamic organ culture system in which CRH secretion from single explants was evaluated by a specific RIA (IR-rCRH). Norepinephrine (NE) stimulated IR-rCRH secretion dose dependently, with peak effects in the nanomolar range. The effect of NE was antagonized by the mixed alpha antagonist phentolamine, the alpha 1 antagonist prazosin, and the alpha 2 antagonist yohimbine, but not by the beta blocker, L-propanolol. Compatible with these data were the findings that the alpha 1 agonist phenylephrine and the alpha 2 agonist clonidine both stimulated IR-rCRH secretion in a dose-dependent fashion. On the other hand, whereas the beta agonist, isoproterenol, caused a weak, non-dose-dependent increase in IR-rCRH secretion, this effect could not be antagonized by L-propanolol. Despite pretreatment with serotonin and acetylcholine antagonists, the effect of NE upon IR-rCRH secretion was undiminished, suggesting that NE...Continue Reading

References

Sep 15, 1992·Biological Psychiatry·K Y LittleW E Stumpf
Nov 13, 1989·Brain Research·S TsagarakisA Grossman
May 1, 1993·Pharmacology, Biochemistry, and Behavior·Z SarnyaiG Telegdy
Oct 24, 1994·Neuroscience Letters·T ShibasakiH Demura
Jan 1, 1994·Brain Research Bulletin·L S Brady
Nov 15, 2002·Survey of Ophthalmology·Evrydiki A BouzasConstantin J Pournaras
Sep 25, 2003·Neuroscience and Biobehavioral Reviews·K C Horner
Dec 28, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Cornelius SchüleGregor Laakmann
Jun 11, 1998·Psychoneuroendocrinology·S G MattaB M Sharp
Mar 1, 1991·Baillière's Clinical Endocrinology and Metabolism·J Licinio, P W Gold
Apr 1, 1993·Baillière's Clinical Endocrinology and Metabolism·S al-Damluji
Jan 13, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Alexander NeumeisterDennis S Charney
Jun 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·Esther M SternbergR L Wilder
Jul 21, 1998·Annals of the New York Academy of Sciences·A E CalogeroR D'Agata
Jul 13, 2002·Annals of the New York Academy of Sciences·Farideh Eskandari, Esther M Sternberg
Feb 16, 2005·Annual Review of Physiology·Evangelia CharmandariG P Chrousos

Citations

Oct 28, 1977·Annals of the New York Academy of Sciences·M T Jones, E W Hillhouse
Jan 1, 1986·Progress in Neurobiology·B L Jacobs
Jan 1, 1971·Acta Physiologica Scandinavica. Supplementum·U Ungerstedt
Jul 1, 1973·European Journal of Clinical Investigation·N J Christensen, O Brandsborg
May 4, 1984·Science·J Axelrod, T D Reisine
Oct 1, 1982·The American Journal of Psychiatry·C R LakeD L Murphy
Jun 1, 1983·Metabolism: Clinical and Experimental·R LanesG Moncada
Jan 1, 1984·Psychopathology·T W UhdeP P Roy-Byrne
Jul 1, 1980·The Journal of Comparative Neurology·S J Wiegand, J L Price

Related Concepts

Organ Culture Techniques
August Rats
Organum Vasculosum Laminae Terminalis
Adrenergic beta-Agonists
Adrenergic alpha-Agonists
Adrenergic alpha-Antagonists
Medihaler-Epi
Intropin
Catecholamines
Corticotropin-Releasing Hormone

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.